{"id":"W3211113743","doi":"10.1136/ijgc-2021-003144","title":"ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Serous carcinoma; Serous fluid; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Oncology; Internal medicine; Carcinoma; Carcinosarcoma; Gynecology; Phases of clinical research; Clinical trial; Cancer; Ovarian cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000687416,0.0008622906,0.001393831,0.0003627583,0.0002513911,0.0009449134,0.0005081596,0.0008393364,0.00331018],"category_scores_gemma":[0.0005785754,0.000376429,0.001235954,0.0003190563,0.0004711332,0.0005785164,0.0002999319,0.002111189,0.0006516312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005127029,"about_ca_system_score_gemma":0.0007430235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00128028,"about_ca_topic_score_gemma":0.004743907,"domain_scores_codex":[0.9998389,0.00006433074,0.000008094829,0.00002353299,0.00001621564,0.00004882374],"domain_scores_gemma":[0.9998404,0.00003305227,0.00003075186,0.00001109806,0.00001068989,0.00007396041],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4947985,0.01705125,0.009148924,0.004958773,0.006006225,0.0002851599,0.0004805436,0.00443952,0.05036347,0.001244292,0.01204029,0.399183],"study_design_scores_gemma":[0.7504023,0.1814871,0.03021737,0.0003728088,0.003453883,0.0005965433,0.000343106,0.002931116,0.005659098,0.0008529074,0.02359056,0.0000933011],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9628738,0.02642105,0.0007039168,0.001326948,0.0004323641,0.00109472,0.001306595,0.0002241619,0.005616461],"genre_scores_gemma":[0.9757375,0.01318477,0.001445396,0.001845997,0.000174429,0.000844839,0.002153612,0.00004546323,0.004567978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00331018,"threshold_uncertainty_score":0.01107365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04614336769951693,"score_gpt":0.3626149689393576,"score_spread":0.3164716012398406,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}